Columbia, Md. — DHA omega-3 innovator Martek Biosciences Corporation
(NASDAQ: MATK) announced today that it’s flagship product, life’sDHA, is
featured in WhiteWave Foods Company’s latest product offering, Horizon Organic
Lowfat Chocolate Milk Plus DHA. This latest addition grows the WhiteWave Foods
life’sDHA portfolio to four product lines offering brain, heart and eye benefits
to the whole family. Horizon Organic Lowfat Chocolate Milk Plus DHA in half
gallons are now available at supermarkets and natural food stores nationwide.
We are pleased to see the Horizon brand expand its life’sDHA portfolio with
healthy, convenient products for the whole family, said David Abramson, Martek
president. life’sDHA is now even more widely available to consumers who want to
incorporate a trusted, vegetarian source of DHA into their diets for brain, eye
and heart health benefits.
“The addition of life’sDHA, a trusted source of DHA Omega-3, to our chocolate
milk is further proof of Horizon’s commitment to offering healthy food options
to families, said Tyler Holm, commercial director for Horizon. Martek is a
valued partner and we are pleased to be working together to bring consumers this
health-enhancing innovation in one more Horizon product that is both good for
you and delicious.”
DHA (docosahexaenoic acid) omega-3 is a long-chain omega-3 fatty acid that
serves as a primary building block for the brain and the eyes and supports
brain, eye and cardiovascular health throughout life. There is a large and
growing body of scientific evidence demonstrating that people of all ages, from
infants to aging adults, benefit from an adequate supply of DHA omega-3 in the
diet. Scientific reviews highlight the importance of DHA omega-3 in proper brain
and eye development and function. Yet despite its importance, Americans have
among the lowest dietary intakes of DHA omega-3 in the world.
Fish are often incorrectly thought to be the only source of DHA omega-3.
However, life’sDHA offers a trusted, vegetarian form of algal DHA that contains
no oceanic pollutants and toxins. Fish are an abundant source of DHA because of
the DHA-rich microalgae in their food chain; life’sDHA is derived from
microalgae and produced in an FDA-inspected facility, from start to finish,
using a sustainable source that does not deplete ocean resources. life’sDHA is
found in numerous foods, beverages and supplements for people of all ages. It is
also the only source of DHA used in U.S. infant formula and is available in more
than 95 percent of the formulas on the U.S. market.
About Horizon
Horizon believes the choice for a healthy family and a healthy planet should be
an easy one. Horizon offers a delicious variety of certified organic dairy
products and innovative natural dairy offerings to satisfy a broad range of
consumer needs. Horizon’s commitment to a healthier planet includes offsetting
the energy used to produce its products with clean, renewable wind power.
Founded in 1991, Horizon was a pioneer in the organic industry, the first
company to supply organic milk nationally, and remains committed to providing
great-tasting dairy products that make it easy for moms to provide nutritious
options for her kids. For more information about Horizon’s organic and natural
dairy products, visit www.horizondairy.com.
About Martek
Martek Biosciences Corporation (NASDAQ: MATK) is a leader in the innovation and
development of DHA omega-3 products that promote health and wellness through
every stage of life. The company produces life’sDHA, a sustainable and
vegetarian source of algal DHA omega-3, for use in foods, beverages, infant
formula, and supplements, and life’sARA (arachidonic acid), an omega-6 fatty
acid, for use in infant formula and growing-up milks. For more information on
Martek Biosciences, visit http://www.martek.com/. For a complete list of
life’sDHA or life’sARA products, visit
http://www.lifesdha.com/.
Sections of this release contain forward-looking statements. These statements
are based upon numerous assumptions which Martek cannot control and involve
risks and uncertainties that could cause actual results to differ. These
statements should be understood in light of the risk factors set forth in the
company’s filings with the Securities and Exchange Commission, including, but
not limited to, the company’s Form 10-K for the fiscal year ended October 31,
2009 and other filed reports on Form 10-K, Form 10-K/A, Form 10-Q and Form 8-K.
To read the rest of this story please go to:
Martek Biosciences Corporation
